A number of new tools are needed, including an animal model that recapitulates the repeat-mediated FMR1 gene silencing seen in FXS and human cell-based/organoid models that can be used to verify the compounds and approaches that work in the animal models. Here, FMR1 is linked to fragile X syndrome.